| Viruses and thyroiditis: an update R Desailloud, D Hober Virology journal 6, 1-14, 2009 | 532 | 2009 |
| Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in dengue-infected patients D Hober, L Poli, B Roblin, P Gestas, E Chungue, G Granic, P Imbert, ... The American journal of tropical medicine and hygiene 48 (3), 324-331, 1993 | 392 | 1993 |
| Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab I Dervite, D Hober, P Morel New England Journal of Medicine 344 (1), 68-69, 2001 | 367 | 2001 |
| Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host D Hober, P Sauter Nature Reviews Endocrinology 6 (5), 279-289, 2010 | 347 | 2010 |
| (−)‐Epigallocatechin‐3‐gallate is a new inhibitor of hepatitis C virus entry N Calland, A Albecka, S Belouzard, C Wychowski, G Duverlie, ... Hepatology 55 (3), 720-729, 2012 | 304 | 2012 |
| Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in β cells W Chehadeh, J Kerr-Conte, F Pattou, G Alm, J Lefebvre, P Wattré, ... Journal of virology 74 (21), 10153-10164, 2000 | 236 | 2000 |
| Increased Level of Interferon-α in Blood of Patients with Insulin-Dependent Diabetes Mellitus: Relationship with Coxsackievirus B Infection W Chehadeh, J Weill, MC Vantyghem, G Alm, J Lefèbvre, P Wattré, ... Journal of Infectious Diseases 181 (6), 1929-1939, 2000 | 225 | 2000 |
| Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy S Aswathyraj, G Arunkumar, EK Alidjinou, D Hober Medical microbiology and immunology 205, 397-407, 2016 | 214 | 2016 |
| Antiviral potential of lactic acid bacteria and their bacteriocins I Al Kassaa, D Hober, M Hamze, NE Chihib, D Drider Probiotics and antimicrobial proteins 6, 177-185, 2014 | 212 | 2014 |
| Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus L Andréoletti, D Hober, C Hober‐Vandenberghe, S Belaich, ... Journal of medical virology 52 (2), 121-127, 1997 | 203 | 1997 |
| Survival of enveloped and non-enveloped viruses on inanimate surfaces S Firquet, S Beaujard, PE Lobert, F Sané, D Caloone, D Izard, D Hober Microbes and environments 30 (2), 140-144, 2015 | 186 | 2015 |
| Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes S Oikarinen, S Tauriainen, D Hober, B Lucas, A Vazeou, A Sioofy-Khojine, ... Diabetes 63 (2), 655-662, 2014 | 178 | 2014 |
| High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19 A Simonnet, I Engelmann, AS Moreau, B Garcia, S Six, A El Kalioubie, ... Infectious Diseases Now 51 (3), 296-299, 2021 | 154 | 2021 |
| Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes H Jaidane, D Hober Diabetes & metabolism 34 (6), 537-548, 2008 | 141 | 2008 |
| Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene V Williams, S Brichler, N Radjef, P Lebon, A Goffard, D Hober, R Fagard, ... Journal of General Virology 90 (11), 2759-2767, 2009 | 135 | 2009 |
| Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. D Hober, A Haque, P Wattre, G Beaucaire, Y Mouton, A Capron Clinical and experimental immunology 78 (3), 329, 1989 | 135 | 1989 |
| High efficiency of functional carbon nanodots as entry inhibitors of herpes simplex virus type 1 A Barras, Q Pagneux, F Sane, Q Wang, R Boukherroub, D Hober, ... ACS applied materials & interfaces 8 (14), 9004-9013, 2016 | 133 | 2016 |
| Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1 Y Gerard, D Hober, M Assicot, S Alfandari, F Ajana, JM Bourez, C Chidiac, ... Journal of Infection 35 (1), 41-46, 1997 | 128 | 1997 |
| The MxA protein levels in whole blood lysates of patients with various viral infections V Chieux, D Hober, J Harvey, G Lion, D Lucidarme, G Forzy, M Duhamel, ... Journal of virological methods 70 (2), 183-191, 1998 | 122 | 1998 |
| Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells K Naghmouchi, J Baah, D Hober, E Jouy, C Rubrecht, F Sané, D Drider Antimicrobial agents and chemotherapy 57 (6), 2719-2725, 2013 | 120 | 2013 |
